Preview: Ascendis Pharma's Earnings
Portfolio Pulse from Benzinga Insights
Ascendis Pharma (NASDAQ:ASND) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $-2.75. The company's past performance shows a pattern of beating EPS estimates, which has often led to an increase in share price. However, the stock has been down 23.91% over the last 52-week period.
November 06, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Ascendis Pharma's upcoming earnings report could potentially impact its stock price. The company has a history of beating EPS estimates, which has often led to a share price increase. However, the stock has been down 23.91% over the last 52-week period.
The upcoming earnings report is a significant event for Ascendis Pharma. If the company beats the EPS estimate as it has in the past, it could lead to a short-term increase in the stock price. However, the overall downward trend of the stock over the past year suggests that there may be other factors at play that could continue to put downward pressure on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100